Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease - Wikidata - wikimedia - TriplyDB

Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease

Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease

http://www.wikidata.org/entity/Q24680221

about

Celiac disease: prevalence, diagnosis, pathogenesis and treatment Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease Tetraploid and hexaploid wheat varieties reveal large differences in expression of alpha-gliadins from homoeologous Gli-2 loci.Review article: coeliac disease, new approaches to therapy.Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation Randomised clinical trial: gluten may cause depression in subjects with non-coeliac gluten sensitivity - an exploratory clinical study.Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin.Transcriptome Analysis of CD4+ T Cells in Coeliac Disease Reveals Imprint of BACH2 and IFNγ Regulation.Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.Possible drug targets for celiac disease.Improving wheat to remove coeliac epitopes but retain functionality Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase).Coeliac disease: current approach and future prospects.Quantitative and qualitative differences in celiac disease epitopes among durum wheat varieties identified through deep RNA-amplicon sequencing.Enzymatic strategies to detoxify gluten: implications for celiac disease.Pharmacotherapy and management strategies for coeliac disease.Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management.Celiac disease: Alternatives to a gluten free diet.A decapeptide from durum wheat prevents celiac peripheral blood lymphocytes from activation by gliadin peptides.Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.

P2860

Q22305490-2986F62A-E480-471E-AEF2-24E009609453 Q33285135-438752C5-744B-411D-B753-4B88E6355752 Q33403049-58FBD245-78FF-4EBE-B57F-86A6A089B0D4 Q34253519-74A1E598-B106-4753-A72B-AA32341D30BE Q34314995-260540E3-D93D-4B82-99F0-DEBE26383C5E Q34413097-AB558F6C-1D84-440B-9B6F-45BD5BCB5036 Q35686518-0E38DB7E-D899-462C-ADCA-B18482CCB879 Q36132402-36D7DDB4-D177-4789-8DCD-C239725EE3C1 Q36345930-AC0609A3-28E4-4B26-B6AE-20B26671E0A7 Q36539486-A2115453-25FA-40BB-892C-E017868B8F2E Q36617620-BDCEE69D-1D61-4180-AFF4-CB1BC8DD22E1 Q37137856-E172303F-A2C7-409C-93E1-01C514ED5DC0 Q37368419-BB258617-D119-463C-87C6-BE98FF591B27 Q37474128-D0095E99-40A6-4000-BCE3-8C5710E4A0F8 Q37806959-2797DA68-D36D-492E-9199-BA40A2A22EBF Q37896092-93ECB68E-A15A-44E0-99B0-58B44734A9C2 Q37965669-188255A9-CCBD-4A4B-B379-6530B91A1877 Q42730481-CCD650A6-0D11-4071-9C1C-70FF5FD9139C Q53578640-F2908067-A372-4009-B3A0-DECC3881935F Q55053101-BE45DCAB-D20B-490F-9D31-56552E9AE442

P2860

Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease

http://www.wikidata.org/entity/Q24680221

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@ast

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@en

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@nl

type

label

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@ast

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@en

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@nl

prefLabel

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@ast

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@en

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@nl

P1433

Q24680221-1979A215-C6D3-49DD-9C7B-AC81A920CC70

P1476

Q24680221-115859DE-F214-4C03-8F69-EF1F9390DFF1

P2093

Q24680221-39E90310-BF68-4A31-B43D-F7103BA17348

Q24680221-BDC493F7-7C1A-4B78-B399-3C2BC1AB1E9E

Q24680221-D1AA8266-B408-46CA-940B-09E35991C6BB

P2860

Q24680221-2B4C299A-3D22-43F5-B2B6-1EBA0D6ABBFE

Q24680221-2C032213-7549-4D19-BD38-81834F2C828F

Q24680221-2CBFF1D2-DF43-4137-B751-7D90F46F5C9D

Q24680221-34806775-9D09-4829-8094-27F5AC607C07

Q24680221-38FBC2D0-C460-4674-8F33-0496A853DE19

Q24680221-39D4C379-CE2D-49CE-B809-BE240DB0BF1A

Q24680221-3A70B27E-722B-49E5-AB55-ED1CBFA0D941

Q24680221-3FC2E874-84A2-4018-B14E-C0C6657FDE5D

Q24680221-4201DD7F-18B9-4002-A22E-06BE4C231F2B

Q24680221-4BD26ABD-2AD5-4A1A-B723-A3E8E29853B2

P304

Q24680221-C7320D1E-22E4-4BC7-AB4D-931F5FAC30F1

P31

Q24680221-489CD15A-6724-40EA-AB83-63DCE9A63093

P356

Q24680221-2CDD95D0-42D9-4628-BECF-0DD088597D8C

P407

Q24680221-8A0E076C-A304-49D7-835E-6758FAEECCE2

P433

Q24680221-B2037402-BDC5-4E4C-A7DD-29BEEA9AF75D

P478

Q24680221-D88D9958-048B-4377-AC56-B6ED69374614

P50

Q24680221-6CBBFCEC-0048-4A68-BDBB-CEECD0FF3131

Q24680221-88B269DD-80EE-45ED-B7D8-10AC29200371

P577

Q24680221-AEAD9194-68F2-46EB-91CC-0544B73FB06B

P5875

Q24680221-4F440944-DFFA-42B0-9360-78C51768BB45

P698

Q24680221-0675B2FC-4895-445D-B6B0-8184E0A56296

P921

Q24680221-05AB8007-924B-48EA-86B2-FC54F7B497F5

P932

Q24680221-F8C476D8-CE95-4EAD-90AB-77D1A4459B36

P356

GUT.2005.064550

P1433

P1476

Antagonists and non-toxic vari ...... ell epitope in coeliac disease

@en

P2093

A V S Hill

http://www.w3.org/2001/XMLSchema#string

D P Jewell

http://www.w3.org/2001/XMLSchema#string

R P Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

Specificity of tissue transglutaminase explains cereal toxicity in celiac disease

The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule

The precipitating factor in coeliac disease.

In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides.

Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.

Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.

T cells in peripheral blood after gluten challenge in coeliac disease.

P304

485-491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2005.064550

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

David A van Heel

P577

2005-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7469673

http://www.w3.org/2001/XMLSchema#string

P698

16299041

http://www.w3.org/2001/XMLSchema#string

P921

P932

1856168

http://www.w3.org/2001/XMLSchema#string